Castle Biosciences, Inc. (CSTL) Unveils Largest Real-World Melanoma Risk Study at ASCO 2025
Castle Biosciences, Inc.
Posts Tagged ‘NASDAQ:CSTL’
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2025 Earnings Call Transcript
Operator: Good afternoon and welcome to Castle Biosciences First Quarter 2025 Conference Call. As a reminder, today's call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2024 Earnings Call Transcript
Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2024 Earnings Call Transcript February 27, 2025Castle Biosciences, Inc. beats earnings expectations.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q3 2024 Earnings Call Transcript
Castle Biosciences, Inc. (NASDAQ:CSTL) Q3 2024 Earnings Call Transcript November 4, 2024Castle Biosciences, Inc. beats earnings expectations.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2024 Earnings Call Transcript
Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2024 Earnings Call Transcript August 5, 2024Castle Biosciences, Inc. beats earnings expectations.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to Castle Biosciences First Quarter 2024 Conference Call. As a remainder, today's call is being recorded.
What Makes Castle Bioscience (CSTL) a Prospective Investment?
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds released “The RiverPark/Next Century Growth Fund” Q4 2023 investor letter...
Does Castle Bioscience (CSTL) Have Robust Growth Prospects?
Next Century Growth Investors, LLC, an investment Management Company, released its “SMID Cap Growth Strategy” fourth-quarter investor letter.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Castle Biosciences Fourth Quarter and Full Year 2023 Conference Call. As a reminder, today's call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q3 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to Castle Biosciences Third Quarter 2023 Conference Call. As a reminder, today’s call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Castle Biosciences Second Quarter 2023 Conference Call. As a reminder, today's call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Castle Biosciences First Quarter 2023 Conference Call. As a reminder, today's call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to Castle Biosciences Fourth Quarter 2022 Conference Call. As a reminder, today's call is being recorded.
Small Caps Begin to Rebound: 5 Stocks to Buy Now
In this article, we discuss 5 rebounding small-cap stocks to buy now.
Is it Still Safe to Invest in Castle Biosciences (CSTL)?
Wasatch Global Investors, an investment management firm, published its "Wasatch Micro Cap Fund" fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Cathie Wood’s Top 15 Small-Cap Stock Picks
In this article, we discuss Cathie Wood’s top 15 small-cap stock picks.
Were Hedge Funds Right About Dumping Castle Biosciences, Inc. (CSTL)?
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need ...
Is CSTL A Good Stock To Buy Now?
In this article you are going to find out whether hedge funds think Castle Biosciences, Inc. (NASDAQ:CSTL) is a good investment right now.
Hedge Funds Are Getting Bullish On Castle Biosciences, Inc. (CSTL)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Are Betting On Castle Biosciences, Inc. (CSTL)
In this article we will check out the progression of hedge fund sentiment towards Castle Biosciences, Inc.
Hedge Funds Have Never Been This Bullish On Castle Biosciences, Inc. (CSTL)
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Hedge Fund and Insider Trading News: David Einhorn, Michael Hintze, Neil Woodford, Och-Ziff Capital Management, Universal Forest Products, Inc. (UFPI), Bristol-Myers Squibb Co (BMY), and More
David Einhorn has earned the attention of the investment community.
